top of page

About the Research

Blurry Background

1. Improving treatment and management of MPS

High-quality and standardized data collection within The Canadian MPS Registry is key to understanding where scientific, clinical and policy efforts should be directed to improve health outcomes for individuals with MPS. The  Canadian MPS Registry will serve to identify priority areas for future clinical trial development to improve health care and quality of life. 

2. Building patient-oriented research capacity

The Canadian MPS Registry aims to collect data that is important and relevant to patients and families. We do this by working with the Canadian MPS Society and with patients and family members who are part of the Registry team. This will promote research  that addresses the needs of patients and families. Furthermore, we hope that patients and families will directly benefit from participation in the Registry. This includes having access to the data they’ve entered and being able to see summarized results within the Registry platform. 

3. Improving rare disease networks

​

The Canadian MPS Registry can facilitate communication between patients/families and researchers, health care providers, and industry partners. 

 

Inform Rare logo
CHEO Research Institute logo
NORD logo
bottom of page